Enanta Pharmaceuticals Inc
(NAS:ENTA)
$
13.2
-0.41 (-2.98%)
Market Cap: 384.31 Mil
Enterprise Value: 250.46 Mil
PE Ratio: 0
PB Ratio: 3.80
GF Score: 56/100 Recent Filings
| Document | Filing Date | Filing Date Price | Document Date | ||
|---|---|---|---|---|---|
| No Filing Data | |||||
Financials
| Document | Filing Date | Filing Date Price | Document Date | ||
|---|---|---|---|---|---|
| No Filing Data | |||||
Ownership
| Document | Filing Date | Filing Date Price | Document Date | ||
|---|---|---|---|---|---|
| No Filing Data | |||||
Material News Releases
| Document | Filing Date | Filing Date Price | Document Date | ||
|---|---|---|---|---|---|
| No Filing Data | |||||
Proxy
| Document | Filing Date | Filing Date Price | Document Date | ||
|---|---|---|---|---|---|
| No Filing Data | |||||
Others
| Document | Filing Date | Filing Date Price | Document Date | ||
|---|---|---|---|---|---|
| No Filing Data | |||||